The Metastatic Prostate Cancer Project

Joel Nowak interviews Dr. Eli Van Allen, a medical oncologist specializing in prostate cancer, from the Broad Institute, an MIT and Dana Farber collaboration and the Dana Farber Hospital about the Metastatic Prostate Cancer Project. The project is a research project created jointly with patients that are reaching out to men with metastatic prostate cancer and asking them to allow the Broad to have access to samples of blood, saliva, tissue (if there is any) and their medical records.

The project will sequence the samples provided and define the genetic map of prostate cancer and evaluate the drugs taken in relation to the genetic discovers made.

The overall goal is to expand the understanding of the genetics of metastatic prostate cancer, develop new drug targets, define prostate cancer subtypes, understand drug resistance, and expand our knowledge of racial differences and prostate cancer genetics and responses.

Men who participate will receive regular communication about the findings of the project. For some men, the discoveries made by the project might be actionable.

You can participate from home; everything will be sent to you in a discreet package. To participate go to www.mpcProject.org and click “Count Me In.” Additional project information is available at https://mpcproject.org/more-details

Read a Transcript of this Podcast

Support the show